Pure Global

Cryogenic spray, cutaneous

Access comprehensive regulatory information for Cryogenic spray, cutaneous in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Emergo Asia Pacific Pty Ltd T/a Emergo Australia, manufactured by CryoConcepts LP in United States of America. The device registration started on June 03, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
Class IIa
Cryogenic spray, cutaneous
Australia TGA ARTG Registered Device
Good Name: Emergo Asia Pacific Pty Ltd T/a Emergo Australia - Cryogenic spray, cutaneous
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

This multi-use disposable device is intended for the removal of target tissue by applying cryogenic gasses at extreme low temperatures. This list below shows examples of the types of lesions that can be treated. โ€ข Lentigo (Age Spots) โ€ข Skin Tags โ€ข Actinic Keratosis (Sun Spots)

Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
June 03, 2021
Effective Date
June 03, 2021
Manufacturer
Country
United States of America
Address
1100 Conroy Place, Easton, PA, 18040